We are live on ! Find out more
SIAU

SB Investment Advisers (UK) Portfolio holdings

AUM $7.73B
1-Year Est. Return 2.35%
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
-2.35%
3 Year Est. Return
+51.59%
5 Year Est. Return
-28.22%
10 Year Est. Return
–
AUM
$11.6B
AUM Growth
+$2.46B
Cap. Flow
+$858M
Cap. Flow %
7.37%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$1.06B

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$146M
2
WORK
Slack Technologies, Inc.
WORK
+$59.7M

Sector Composition

Rank Sector Weight
1 Technology 69.64%
2 Healthcare 30.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBER icon
1
Uber
UBER
$153B
$8.11B 69.64%
222,228,178
– –
GH icon
2
Guardant Health
GH
$22.6B
$1.57B 13.48%
14,037,960
– –
RLAY icon
3
Relay Therapeutics
RLAY
$4.33B
$1.19B 10.21%
+27,904,963
New +$1.06B
VIR icon
4
Vir Biotechnology
VIR
$1.49B
$776M 6.67%
22,616,666
– –
TXG icon
5
10x Genomics
TXG
$6.61B
– –
-1,639,901
Closed -$146M
WORK
6
DELISTED
Slack Technologies, Inc.
WORK
– –
-1,919,153
Closed -$59.7M

Similar funds

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

SB Investment Advisers (UK)'s Q3 2020 Portfolio in Review

As of Q3 2020, SB Investment Advisers (UK) held 6 positions worth $11.6B, up 27% from $9.18B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SB Investment Advisers (UK) deployed $858M of net new capital in Q3 2020, opening 1 new position. Its largest new stake was Relay Therapeutics: 27,904,963 shares worth $1.19B.

By sector, the portfolio is most concentrated in Technology at 70% of assets, down from 76% a quarter earlier, followed by Healthcare.

On the sell side, the most notable exit was 10x Genomics, an estimated $146M sold.

  • SB Investment Advisers (UK)'s largest Q3 2020 buy was Relay Therapeutics: 27,904,963 shares worth $1.19B.
  • SB Investment Advisers (UK) fully exited 10x Genomics in Q3 2020, selling an estimated $146M.
  • SB Investment Advisers (UK)'s ten largest holdings make up 100% of its $11.6B portfolio in Q3 2020.
  • SB Investment Advisers (UK) opened 1 new position and closed 2 in Q3 2020.
  • SB Investment Advisers (UK)'s portfolio value rose 27% quarter-over-quarter to $11.6B.

Based on SB Investment Advisers (UK)'s 13F filing for Q3 2020, filed 16 Nov 2020.